06/14/2021: Lab Alert: Sodium Citrate Blood Specimen Collection Tubes in Short Supply
Audience: Clinical Laboratory Professionals
Level: Laboratory Alert
The US is experiencing significant interruptions in the supply of sodium citrate blood specimen collection (light blue top) tubes because of an unprecedented increase in demand and the recent vendor supply challenges, due in part to a recall. The U.S. Food and Drug Administration (FDA) recently issued a Letter to Health Care and Laboratory Personnel that recommends the following conservation strategies:
- Do not use sodium citrate (light blue top) tubes unless medically necessary.
- Do not include sodium citrate (light blue top) tubes in routine collections of a variety of specimens at the time of other blood sampling or IV insertion.
- Do not use sodium citrate (light blue top) tubes as discard tubes; consider clear top or red stopper (no additive) tubes as an alternative.
- Limit allocation of 1.8mL sodium citrate (light blue top) tubes for difficult blood collections.
FDA will provide updated information to the public as it becomes available.
- Testing Strategies for SARS-CoV-2
- Information for Laboratories about Coronavirus (COVID-19)
- Frequently Asked Questions about Coronavirus (COVID-19) for Laboratories
- CDC Coronavirus (COVID-19) Website
- CDC Laboratory Outreach Communication System (LOCS)
- Clinical Laboratory COVID-19 Response Calls
For questions, contact us at LOCS@cdc.gov.